AEON Biopharma, Inc.
Pharmaceutical Preparations · ALISO VIEJO · CA
Moderate confidence (50%)
Updated Oct 17, 2026, 12:03 AM
What is happening
Derived by rule set status-rules-2026.09.7
An exchange warned the company it no longer meets the listing standards. Companies regain compliance often.
Latest material event: AEON Biopharma, Inc. received a delisting notice from its exchange (Mar 31, 2026)
Timeline
Every material event, newest first. History is never overwritten.
AEON Biopharma, Inc. received a delisting notice from its exchange
Mar 31, 2026
Delisting notice received
- SEC EDGAR — “Item 3.01. Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. On March 31, 2026, AEON Biopharma, Inc. (the Company or AEON ) received an additional written notice of non-compliance (the Notice ) from NYSE American LLC ( NYSE American ) indicating that the Company is not in compliance with the continued listing standards set forth in Section 1003(a)(ii) of the NYSE American Company Guide (the Company Guide ). Section 1003(a)(ii) requires stockholders equity of $4.0 million or more if a listed company has reported losses from continuing operation…”
Company information
- Founded
- —
- Employees (estimate)
- —
- Industry
- Pharmaceutical Preparations
- Subindustry
- —
- Listing
- SEC lists the ticker AEON on NYSE.
- SEC CIK
- 0001837607
- Website
- —
- —
- Headquarters
- ALISO VIEJO, CA
- Also known as
- Priveterra Acquisition Corp.
- Legal entities
- AEON Biopharma, Inc.
Sources
Every material source used to build this profile.
SEC Company Submissions (TIER 1 · UNVERIFIED)
AEON Biopharma, Inc. — Pharmaceutical Preparations (SIC 2834) — ALISO VIEJO, CA
View source recordSEC EDGAR (TIER 1 · UNVERIFIED)
Item 3.01. Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. On March 31, 2026, AEON Biopharma, Inc. (the Company or AEON ) received an additional written notice of non-compliance (the Notice ) from NYSE American LLC ( NYSE American ) indicating that the Company is not in compliance with the continued listing standards set forth in Section 1003(a)(ii) of the NYSE American Company Guide (the Company Guide ). Section 1003(a)(ii) requires stockholders equity of $4.0 million or more if a listed company has reported losses from continuing operation…
View source record
Status history
Every derived status, with the rule that produced it.
- DISTRESS_SIGNAL → DISTRESS_SIGNALLISTING_STANDARDS_WARNING · Sep 18, 2026, 01:33 AM
An exchange warned the company it no longer meets the listing standards. Companies regain compliance often.
- DISTRESS_SIGNAL → DISTRESS_SIGNALLISTING_STANDARDS_WARNING · Sep 18, 2026, 01:14 AM
An exchange warned the company it no longer meets the listing standards. Companies regain compliance often.
- DISTRESS_SIGNAL → DISTRESS_SIGNALPUBLIC_LISTING_ENDED · Sep 15, 2026, 12:32 PM
An exchange warned the company it no longer meets the listing standards. Companies regain compliance often.
- DISTRESS_SIGNAL → DISTRESS_SIGNALPUBLIC_LISTING_ENDED · Sep 13, 2026, 12:05 AM
An exchange warned the company it no longer meets the listing standards. Companies regain compliance often.
- UNKNOWN → DISTRESS_SIGNALPUBLIC_LISTING_ENDED · Sep 8, 2026, 04:24 AM
An exchange warned the company it no longer meets the listing standards. Companies regain compliance often.